Global Neurointerventional Device Market

MARKET SCOPE:

The global neurointerventional device market is projected to grow significantly, registering a CAGR of 7.1% during the forecast period (2026 – 2034).

The neurointerventional device market growth is primarily fueled by rising incidences of neurological disorders. With aging populations worldwide, the prevalence of diseases like ischemic and hemorrhagic stroke, brain aneurysms, and arteriovenous malformations is rising exponentially. Lifestyle risk factors—such as hypertension, obesity, and smoking—also add to this expansion. As stroke remains the leading cause of death and disability worldwide, healthcare systems are placing greater emphasis on expedited diagnosis and interventional treatments, targeting investment in devices like thrombectomy devices, flow diverters, embolic coils, and guidewires. These minimally invasive procedures offer enhanced safety, decreased hospital stay, and enhanced patient outcomes, and are being increasingly selected over open-brain surgeries

Technological innovation and greater financing are another key driver of growth. Imaging breakthroughs (high‑resolution angiography, real‑time 3D visualization, etc.), AI‑driven navigation, robotic‑assisted catheter systems, and advanced biomaterials enhance precision, safety, and workflow efficiency. Artificial intelligence and machine learning integration also expand diagnostic sensitivity and procedural planning. In parallel, robust financial backing—venture capital, government incentives, and corporate R&D funds—drives product development, clinical testing, and regulatory clearance. In addition, improved reimbursement schemes in developed economies encourage providers to embrace these advanced devices, cementing the shift to patient‑focused, minimally invasive neurovascular treatment.

MARKET OVERVIEW:

Driver: Rising Prevalence of Stroke and Aneurysms Fueling Demand for Neurointerventional Devices

The rising incidence of neurological diseases such as ischemic strokes, brain aneurysms, and arteriovenous malformations is one of the key drivers for the neurointerventional device market. Sedentary life, advanced age, and rising incidence of hypertension and diabetes are some of the factors that account for a heightened stroke risk. As strokes continue to be among the most prevalent causes of long-term disability and death across the world, attention is growing towards less invasive interventions allowing quick recovery and better outcomes. Neurointerventional devices such as stent retrievers, embolic coils, and aspiration catheters are of utmost significance in the restoration of blood flow, reduction of brain damage, and prevention of life-threatening complications.

Also, increasing awareness among patients and medical professionals regarding the benefits of early neurovascular intervention is fueling the uptake of these devices. Government and healthcare organizations are launching stroke prevention and rapid response programs, which will further augment demand for sophisticated interventional devices. With more and more hospitals establishing neurointerventional centers, demand for innovative and effective devices will increase manyfold in the coming years.

Restraint: High Costs and Limited Accessibility in Emerging Markets

Despite their life-saving potential, neurointerventional devices remain costly and often inaccessible in low- and middle-income countries. These interventions need specialized centers, trained staff, and high-technology imaging equipment, all of which contribute a major portion of the expense. Where the infrastructure of health is not good and the coverage of insurance is also low, patients are not in a position to pay for such upscale therapies. Therefore, adoption is still high in developed economies with improved reimbursement mechanisms and health financing.

Furthermore, the necessity to update technology on a regular basis places a burden on the clinics and the hospitals to maintain costly new systems. This dissuades small institutions from entering the market and restricts their geographic span of neurointerventional solutions. Without concrete measures to lower the costs and expand training programs, market penetration in developing markets could be low.

Opportunity: Advancements in Imaging, AI, and Robotic-Assisted Navigation

Technological innovation is a significant market potential in the neurointerventional device market. New technologies such as 3D real-time imaging, AI-based navigation systems, and robotic-assisted catheterization are transforming the performance of intricate neurovascular procedures. These devices enhance procedural accuracy, reduce operative risks, and shorten recovery times, thereby making intervention more efficient and accessible.

Along with this, the integration of AI and machine learning algorithms in diagnostic technologies allows clinicians to recognize abnormalities and blockages more swiftly and accurately. Not only does this improve clinical outcomes, but it also reduces time-sensitive error in stroke management. With the cost-effectiveness and scalability of these technologies increasing, they are likely to expand access to high-quality neurointerventional care to more patient groups, opening up new market growth and innovation opportunities.

SEGMENTATION ANALYSIS:

The Hospital Segment is anticipated to grow significantly during the forecast period

The hospital segment in the neurointerventional device market is expected to maintain its dominant position during the forecast period due to the high volume of complex neurological procedures performed in these facilities. Hospitals have state-of-the-art imaging technology, hybrid operating suites, and trained medical staff and are thus the first choice for emergency surgery for stroke management, aneurysm clipping, and other neurovascular conditions. Robust reimbursement networks, increasing patient hospitalizations for neurological emergencies, and government-sponsored stroke initiatives are also driving hospital infrastructure growth, further accelerating the uptake of neurointerventional devices in this arena. As a result, hospitals continue to lead the market in terms of both usage and revenue contribution.

REGIONAL ANALYSIS:

The North America region is set to witness significant growth during the forecast period.

The North America neurointerventional device market is expected to witness substantial growth during the forecast period, driven by the increasing prevalence of neurological disorders such as ischemic stroke, brain aneurysms, and arteriovenous malformations. The United States of America command a huge market share due to the fact that they have a well-established healthcare infrastructure, advanced imaging technologies, and a strong density of experienced neurosurgeons. Greater patient awareness, strong reimbursement systems, and ongoing FDA approvals for new neurointerventional products are also responsible for propelling the region to the top. Moreover, the growing adoption of minimally invasive stroke management and the favorable government policies are driving North America's supremacy in the international market.

In Contrast, the Asia Pacific neurointerventional device market is also the fastest-growing region because of the rapid aging population, rise in the incidence of stroke, and rising healthcare access in countries like China, India, and Japan. Upgrade of medical infrastructure at the government level, rising investment in sophisticated neurosurgical equipment, and development of private healthcare facilities are driving demand for neurointerventional procedures. Medical tourism and affordable treatment are also drawing foreign patients to the region. Moreover, partnerships between international device companies and local healthcare providers are improving product supply and physician training, thus making Asia Pacific an important driver of neurointerventional device market growth over the next few years.

COMPETITIVE ANALYSIS:

The global neurointerventional device market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.

Insera Therapeutics Inc

Stryker

Johnson and Johnson Services Inc

Penumbra, Inc

NeuroVasc Technologies

Perflow Medical Ltd.

Microport Scientific Corporation

MicroVention Inc

Codman Neuro

Terumo Corporation

Medtronic

Anaconda Biomed S.L.

Recent Development:

In April 2025, Anaconda Biomed S.L. enrolled the first U.S. patient in its pivotal ATHENA clinical trial for the ANA Funnel Catheter. This device is designed for treating acute ischemic stroke by improving clot retrieval efficiency.

In July 2024, Terumo Corporation, through its neurovascular division MicroVention Inc., released positive one-year results from the CLEVER study for the WEB™ 17 device.

In June 2024, MicroPort Scientific Corporation received NMPA approval in China for its PathFinder™ carotid balloon dilation catheter. Additionally, the company expanded internationally by completing the first Tubridge™ flow diverter implantation in Brazil and launching its NUMEN™ embolization coil in France, which also gained insurance reimbursement coverage.

SCOPE OF THE REPORT:

By Indication

• Brain Aneurysm
• Stroke
• Others

By Product

• Embolic Coils
• Catheter
• Stents
• Wires
• Others

By Application

• Ambulatory Surgical Center (ASC)
• Hospitals
• Others

By Region

• North America (United States & Canada)
• Europe (Germany, UK, France, Spain, Italy and Rest of Europe)
• Asia-Pacific (China, Japan, India, South Korea, Australia and Rest of Asia-Pacific)
• Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa and Rest of Middle East and Africa)

KEY REASONS TO PURCHASE THIS REPORT:

It provides a technological development map over time to understand the industry’s growth rate and indicates how the neurointerventional device market is evolving.

The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which neurointerventional device submarket will be the main driver of the overall market from 2026 to 2034.

It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.

It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2034 and which country will lead the market in 2034. Show more